Asia’s largest Life-Sciences and healthcare forum, BioAsia is going to present ‘Startups Stage’, a dedicated platform in its 16^th Edition of the event to be held on Februrary 25-27, 2019 at Hyderabad. Enabling entrepreneurs working on solutions for pharma, bio-tech, life sciences, health-tech, med-tech sectors, Startup Stage will showcase their innovation to a global audience. The diverse attendance of healthcare leaders from over 50 countries routinely has given BioAsia a reputation of being a globally sought after annual forum. In light of BioAsia’s great potential for emerging entrepreneurs, the conference regularly showcases startups with a potential to address the global healthcare challenges and India’s diverse healthcare needs. Shakthi Nagappan, CEO, BioAsia speaks “It has been our endeavor to showcase start-ups with potential to transform healthcare. 2019 event will have an increased start-up focus. We are delighted with enthusiastic response from the Life Sciences Industry leaders, Venture capital & Angel investor community and the corporate M&A teams of leading pharma & bio-tech companies,” 

Here, the platform will allow the participating startups to essay their solutions at the International Tradeshow Exhibition, network with global industry delegates, seek mentorship from eminent thought leaders, seek partnership avenues with companies & pitch to leading venture and M & A investors. The participating startups will get a chance to have interaction with Notable Healthcare Investors like Mr. Kris Gopalakrishnan (Axilor), Mr. Sanjiv Kaul (ChrysCapital), Mr. Atin Sharma (RoundGlass Partners), Mr. Sandeep Roperia (Abraaj), Mr. Pranay Adhvaryu (Lighthouse Canton), Mr. Arpit Beri (Shunwei Capital, Mr. Mohan Kumar (Norwest Venture Partners), Mr.Mahadevan (Mahad) Narayanamoni (TPG), Mr. Jinesh Shah (Omnivore) and representatives from 3one4 Capital, Kae Capital, Kalaari, Patni Family Office, Ivy Cap Ventures, and also explore funding opportunities. Apart from this, Dr. Renu Swarup (Secretary, Department of Biotechnology), Government of India has been instrumental in accelerating the growth of biotech sector in the country. Further, she will interact with the Start-ups in the Start-up Stage. M&A teams from companies like Zydus Cadila, Dr. Reddy’s Laboratories, Alkem Laboratories, etc. will also participate in the event. Since last 4 years, BioAsia is providing opportunity to around 150 Startups which benefitted by networking with Industry experts along with their feedback and investors community to explore their funding requirements.

This opportunistic event has witnessed a prestigious participant history including the likes of several Nobel Prize winners including the likes of Dr’s Kurt Wuthrich, Ada Yonath, Harald zur Hausen, Barry Marshall, Martin J Evans, several Lasker Awardees and eminent industry leaders like Dr. Paul Stoffels (Vice Chairman and CSO, J&J), Dr. Vas Narasimhan (CEO, Novartis), Dr. Patrick Vallance (President R&D, GSK), Dr. Seth Berkley (CEO, GAVI), Dr. Freida Lewis Hall (EVP and CMO, Pfizer), Dr. Mark Caulfield (Chief Scientist, Genomics England), Shri Pankaj Patel (Chairman, Zydus Cadila), Mr. Satish Reddy (Chairman, Dr. Reddy’s Laboratories), Ms. Kiran Majumdar Shaw (CMD, Biocon), among others.

On the Occasion of the Startup stage, Mr. Jayesh Ranjan IAS, Principal Secretary, Industries & Commerce, Government of Telangana commented, “Start-up Stage @ BioAsia will bring together the most cutting-edge, innovative and technically astute start-ups from the realm of life sciences and healthcare sectors. The platform will provide an unparalleled opportunity to startups to showcase their solutions and connect with a global network of industry stakeholders across the sectors. Most importantly, the event will facilitate conversation between the Start-ups and the Governments, as the Government is becoming the most important customer of the Start-ups. We are glad that Government of India and a number of other State Governments have partnered with us on this initiative”.

Big and influential organizations have joined together for the start-up stage including Startup India, Department of Biotechnology, BIRAC, Telangana State Innovation Cell, NASSCOM, T-Hub, Research and Innovation Circle of Hyderabad, Ernst and Young, inc42, Mumbai Angels, IKP, Light House Canton, among others. With such an extraordinary ensemble of investors, Government & Industry stakeholders, M&A teams from Pharma Companies.

Read More news:

LG joins Microsoft to accelerate autonomous vehicles business

'AI in activity trackers, smartwatches threatening privacy of health data'